Has Keila Hoover received payments from drug or device companies?

Yes. Drug and device makers reported $33,740,960 in general payments to Keila Hoover across 8,627 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Keila Hoover did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Keila Hoover come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Keila Hoover

Family Medicine · Miami, FLNPI 1417909375

Payments from drug & device makers

$33,740,960in general payments, 2019–2025

Across 8,627 payments — averaging $3911.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Modernatx, Inc.$16.3M
Pfizer$3.5M
AstraZeneca$1.9M
Sumitomo Pharma America, Inc.$1.9M
Supernus Pharmaceuticals, Inc.$1.6M
Otsuka Pharmaceutical Development & Commercialization, Inc.$1.2M
plus $7.3M from 43 others

$1,070,497in research payments, 2019–2025

Across 51 payments — averaging $20,990 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

First Wave Biopharma, Inc.$1.1M
Eli Lilly$5K

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Modernatx, Inc.	5,662	$16,305,514
Pfizer	127	$3,450,713
AstraZeneca	14	$1,942,104
Sumitomo Pharma America, Inc.	318	$1,939,567
Supernus Pharmaceuticals, Inc.	76	$1,554,648
Otsuka Pharmaceutical Development & Commercialization, Inc.	5	$1,241,053
Exeltis, USA Inc.	390	$1,122,124
Organon	120	$1,056,613
Janssen Research & Development, LLC	62	$821,921
Abbott	15	$770,954
Regeneron	1,494	$738,117
Astrazeneca UK Limited	8	$495,655
Cue Health Inc.	2	$391,591
Alk-abello, Inc	78	$333,422
Merck	11	$306,300
Cipla USA Inc.	9	$223,497
Myovant Sciences GmbH	58	$201,625
Sanofi US Services Inc.	19	$183,028
American Regent	20	$155,436
Welch Allyn	9	$145,879
AbbVie(2 entities)	15	$101,155
Amgen(2 entities)	13	$95,400
Teva Pharmaceuticals USA, Inc.	23	$83,354
Myovant Sciences Inc.	9	$43,774
Sanofi Pasteur Inc.	4	$30,000
Novartis	5	$4,343
First Wave Biopharma, Inc.	1	$1,400
Kowa Research Institute, Inc.	5	$1,029
Medtronic	2	$165
Kvk-tech, Inc.	21	$102
Amarin Pharma, Inc.	5	$69
Clarus Therapeutics Inc.	3	$48
Xeris Pharmaceuticals, Inc.	2	$44
Antares Pharma, Inc.	3	$42
GSK	3	$39
Takeda Pharmaceuticals U.S.A., Inc.	2	$30
Lilly USA, LLC	2	$26
Genentech USA, Inc.	1	$21
Organogenesis Inc.	1	$20
Siemens Medical Solutions USA, Inc.	1	$16
Johnson & Johnson	1	$16
Biohaven Pharmaceutical Holding Company Ltd.	1	$15
Eisai Inc.	1	$15
Upsher-smith Laboratories LLC	1	$15
Esperion Therapeutics, Inc.	1	$15
Scilex Pharmaceuticals Inc.	1	$13
Mission Pharmacal Company	1	$12
Sanofi-aventis U.S. LLC	1	$11
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	1	$11

How this compares

$33,740,960 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida →

Other family medicine in Miami

Jorge CasoMiami$22.6M
David WyattMiami$13.7M
Jose CardenasMiami$13.2M
Lazaro GarciaMiami$10.3M
Ibrahim Menendez PerezMiami$8.9M
Aniel Navarro MarinMiami$7.3M
Gilberto SecoMiami$6.8M
Ramon LeonMiami$6.3M
Eddy CapoteMiami$6.2M
Erick JuarezMiami$5.9M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →